- Home
- DOCS vs SNN Comparison
DOCS vs SNN Comparison
Compare DOCS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- SNN
- Stock Information
- Founded
- DOCS 2010
- SNN 1856
- Country
- DOCS United States
- SNN United Kingdom
- Employees
- DOCS N/A
- SNN N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- SNN Industrial Specialties
- Sector
- DOCS Technology
- SNN Health Care
- Exchange
- DOCS Nasdaq
- SNN Nasdaq
- Market Cap
- DOCS 11.4B
- SNN 13.2B
- IPO Year
- DOCS 2021
- SNN 1999
- Fundamental
- Price
- DOCS $57.30
- SNN $30.85
- Analyst Decision
- DOCS Buy
- SNN Hold
- Analyst Count
- DOCS 17
- SNN 3
- Target Price
- DOCS $64.41
- SNN $27.50
- AVG Volume (30 Days)
- DOCS 1.5M
- SNN 1.1M
- Earning Date
- DOCS 08-07-2025
- SNN 08-08-2025
- Dividend Yield
- DOCS N/A
- SNN 2.35%
- EPS Growth
- DOCS 54.17
- SNN 56.15
- EPS
- DOCS 1.11
- SNN 0.47
- Revenue
- DOCS $570,399,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- DOCS $11.98
- SNN $6.87
- Revenue Next Year
- DOCS $10.49
- SNN $5.19
- P/E Ratio
- DOCS $51.65
- SNN $32.54
- Revenue Growth
- DOCS 19.98
- SNN 4.70
- 52 Week Low
- DOCS $25.00
- SNN $23.69
- 52 Week High
- DOCS $85.21
- SNN $31.84
- Technical
- Relative Strength Index (RSI)
- DOCS 40.07
- SNN 53.38
- Support Level
- DOCS $60.09
- SNN $31.09
- Resistance Level
- DOCS $62.31
- SNN $31.60
- Average True Range (ATR)
- DOCS 1.64
- SNN 0.41
- MACD
- DOCS -0.52
- SNN -0.03
- Stochastic Oscillator
- DOCS 14.04
- SNN 61.48
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.